These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 773413)

  • 1. The treatment of vitiligo with topical corticosteroids. Light and electronmicroscopic studies.
    Bleehen SS
    Br J Dermatol; 1976 Mar; 94 suppl 12():43-50. PubMed ID: 773413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PUVA-induced repigmentation of vitiligo: a histochemical (split-DOPA) and ultrastructural study.
    Ortonne JP; MacDonald DM; Micoud A; Thivolet J
    Br J Dermatol; 1979 Jul; 101(1):1-12. PubMed ID: 113025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A clinical trial of clobetasol propionate in Filipino vitiligo patients.
    Geraldez CB; Gutierrez GT
    Clin Ther; 1987; 9(5):474-82. PubMed ID: 3311364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind, randomized trial of 0.05% betamethasone vs. topical catalase/dismutase superoxide in vitiligo.
    Sanclemente G; Garcia JJ; Zuleta JJ; Diehl C; Correa C; Falabella R
    J Eur Acad Dermatol Venereol; 2008 Nov; 22(11):1359-64. PubMed ID: 18624857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical delivery of clobetasol propionate loaded microemulsion based gel for effective treatment of vitiligo--part II: rheological characterization and in vivo assessment through dermatopharmacokinetic and pilot clinical studies.
    Patel HK; Barot BS; Parejiya PB; Shelat PK; Shukla A
    Colloids Surf B Biointerfaces; 2014 Jul; 119():145-53. PubMed ID: 24767976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo.
    Lepe V; Moncada B; Castanedo-Cazares JP; Torres-Alvarez MB; Ortiz CA; Torres-Rubalcava AB
    Arch Dermatol; 2003 May; 139(5):581-5. PubMed ID: 12756094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Once-daily application of calcipotriene 0.005%-betamethasone dipropionate 0.064% ointment for repigmentation of facial vitiligo.
    Newman MD; Silverberg NB
    Cutis; 2011 Nov; 88(5):256-9. PubMed ID: 22272490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Repigmentation of vitiligo induced by oral photochemotherapy. Histoenzymological and ultrastructural study (author's transl)].
    Ortonne JP; MacDonald DM; Micoud A; Thivolet J
    Ann Dermatol Venereol; 1978 Nov; 105(11):939-40. PubMed ID: 754609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitiligo treated with topical clobetasol propionate.
    Kumari J
    Arch Dermatol; 1984 May; 120(5):631-5. PubMed ID: 6721525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repigmentation of vitiligo macules treated topically with Efudix cream.
    Szekeres E; Morvay M
    Dermatologica; 1985; 171(1):55-9. PubMed ID: 4029463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical comparison of halcinonide and betamethasone valerate in common dermatoses.
    Turnbull BC
    Australas J Dermatol; 1975 Apr; 16(1):17-9. PubMed ID: 1108858
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of vitiligo with Sicorten ointment (preliminary report).
    Han GZ; Shao CG; Ye GY; Liu XQ
    Proc Chin Acad Med Sci Peking Union Med Coll; 1986; 1(1):62-3. PubMed ID: 3422996
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of PUVA therapy on melanocytes and keratinocytes in non-segmental vitiligo: histopathological, immuno-histochemical and ultrastructural study.
    Anbar TS; El-Sawy AE; Attia SK; Barakat MT; Moftah NH; El-Ammawy TS; Abdel-Rahman AT; El-Tonsy MH
    Photodermatol Photoimmunol Photomed; 2012 Feb; 28(1):17-25. PubMed ID: 22211999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical 0.05% clobetasol propionate versus 1% pimecrolimus ointment in vitiligo.
    Coskun B; Saral Y; Turgut D
    Eur J Dermatol; 2005; 15(2):88-91. PubMed ID: 15757818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of hair follicles in the repigmentation of vitiligo.
    Cui J; Shen LY; Wang GC
    J Invest Dermatol; 1991 Sep; 97(3):410-6. PubMed ID: 1714927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of prolonged treatment with levamisole on vitiligo with limited and slow-spreading disease.
    Pasricha JS; Khera V
    Int J Dermatol; 1994 Aug; 33(8):584-7. PubMed ID: 7960359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trial comparing hydrocortisone 17-butyrate to betamethasone 17-valerate in a series of patients with eczematous skin diseases.
    Thormann J; Brodthagen H
    Dermatologica; 1976; 152 Suppl 1():209-14. PubMed ID: 782955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pemphigoid and pemphigus foliaceus successfully treated with topical corticosteroids.
    Muramatsu T; Iida T; Shirai T
    J Dermatol; 1996 Oct; 23(10):683-8. PubMed ID: 8973033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Autologous epidermal grafting plus sicorten cream in the treatment of vitiligo].
    Li CQ; Liu ZR; Shi W
    Hunan Yi Ke Da Xue Xue Bao; 2000 Jun; 25(3):312, 314. PubMed ID: 12212184
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of topical calcipotriol, betamethasone dipropionate and their combination in the treatment of localized vitiligo.
    Kumaran MS; Kaur I; Kumar B
    J Eur Acad Dermatol Venereol; 2006 Mar; 20(3):269-73. PubMed ID: 16503885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.